1. A randomised Phase II trial of carboplatin and gemcitabine ± vandetanib in first‐line treatment of patients with advanced urothelial cell cancer not suitable to receive cisplatin. (19th May 2020) Authors: Jones, Robert; Crabb, Simon; Chester, John; Elliott, Tony; Huddart, Robert; Birtle, Alison; Evans, Linda; Lester, Jason; Jagdev, Satinder; Casbard, Angela; Huang, Chao; Madden, Tracie‐Ann; Griffiths, Gareth Journal: BJU international Issue: Volume 126:Number 2(2020) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. Issue 10232 (18th April 2020) Authors: Birtle, Alison; Johnson, Mark; Chester, John; Jones, Robert; Dolling, David; Bryan, Richard T; Harris, Christopher; Winterbottom, Andrew; Blacker, Anthony; Catto, James W F; Chakraborti, Prabir; Donovan, Jenny L; Elliott, Paul Anthony; French, Ann; Jagdev, Satinder; Jenkins, Benjamin; Keeley, Fra... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy. (29th May 2017) Authors: Huddart, Robert A.; Birtle, Alison; Maynard, Lauren; Beresford, Mark; Blazeby, Jane; Donovan, Jenny; Kelly, John D.; Kirkbank, Tony; McLaren, Duncan B.; Mead, Graham; Moynihan, Clare; Persad, Raj; Scrase, Christopher; Lewis, Rebecca; Hall, Emma Journal: BJU international Issue: Volume 120:Number 5(2017) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database. (January 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Le Moulec, Sylvestre; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; De Giorgi, Ugo; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 125(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Issue 8 (August 2016) Authors: Dearnaley, David; Syndikus, Isabel; Mossop, Helen; Khoo, Vincent; Birtle, Alison; Bloomfield, David; Graham, John; Kirkbride, Peter; Logue, John; Malik, Zafar; Money-Kyrle, Julian; O'Sullivan, Joe M; Panades, Miguel; Parker, Chris; Patterson, Helen; Scrase, Christopher; Staffurth, John; Stockdale... Journal: Lancet oncology Issue: Volume 17:Issue 8(2016:Aug.) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Le Moulec, Sylvestre; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; De Giorgi, Ugo; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost‐effectiveness of zoledronic acid and strontium‐89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate‐refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747). (10th July 2016) Authors: Andronis, Lazaros; Goranitis, Ilias; Pirrie, Sarah; Pope, Ann; Barton, Darren; Collins, Stuart; Daunton, Adam; McLaren, Duncan; O'Sullivan, Joe M.; Parker, Chris; Porfiri, Emilio; Staffurth, John; Stanley, Andrew; Wylie, James; Beesley, Sharon; Birtle, Alison; Brown, Janet E.; Chakraborti, Prabir... Journal: BJU international Issue: Volume 119:Number 4(2017) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer. (July 2018) Authors: Thibault, Constance; Eymard, Jean-Christophe; Birtle, Alison; Krainer, Michael; Baciarello, Giulia; Fléchon, Aude; Le Moulec, Sylvestre; Spaeth, Dominique; Laguerre, Brigitte; Caffo, Orazio; Deville, Jean-Laurent; Beuzeboc, Phillipe; Hasbini, Ali; Gross-Goupil, Marine; Helissey, Carole; Bennamoun... Journal: European journal of cancer Issue: Volume 97(2018) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Moulec, Sylvestre Le; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; Giorgi, Ugo De; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗